Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.

Bhasin S, Travison TG, Storer TW, Lakshman K, Kaushik M, Mazer NA, Ngyuen AH, Davda MN, Jara H, Aakil A, Anderson S, Knapp PE, Hanka S, Mohammed N, Daou P, Miciek R, Ulloor J, Zhang A, Brooks B, Orwoll K, Hede-Brierley L, Eder R, Elmi A, Bhasin G, Collins L, Singh R, Basaria S.

JAMA. 2012 Mar 7;307(9):931-9. doi: 10.1001/jama.2012.227.

PMID:
22396515
2.

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

Eur Urol. 2000 Apr;37(4):367-80. Review.

PMID:
10765065
3.

The effect of 5α-reductase inhibitors on prostate growth in men receiving testosterone replacement therapy: a systematic review and meta-analysis.

Cui Y, Zong H, Yang C, Yan H, Zhang Y.

Int Urol Nephrol. 2013 Aug;45(4):979-87. doi: 10.1007/s11255-013-0477-0. Epub 2013 Jun 1. Review.

PMID:
23728850
4.

The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.

Tindall DJ, Rittmaster RS.

J Urol. 2008 Apr;179(4):1235-42. doi: 10.1016/j.juro.2007.11.033. Epub 2008 Feb 20. Review. Erratum in: J Urol. 2008 Jun;179(6):2490.

5.

Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia.

Djavan B, Milani S, Fong YK.

Expert Opin Pharmacother. 2005 Feb;6(2):311-7. Review. Erratum in: Expert Opin Pharmacother. 2005 Apr;6(4):681.

PMID:
15757426
6.

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

World J Urol. 2002 Apr;19(6):413-25. Review.

PMID:
12022710
7.
8.

Chemoprevention using dutasteride: the REDUCE trial.

Gomella LG.

Curr Opin Urol. 2005 Jan;15(1):29-32. Review.

PMID:
15586026
9.

Targeting 5α-reductase for prostate cancer prevention and treatment.

Nacusi LP, Tindall DJ.

Nat Rev Urol. 2011 May 31;8(7):378-84. doi: 10.1038/nrurol.2011.67. Review.

10.
11.

Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study Review.

Thareja S.

Chem Rev. 2015 Apr 22;115(8):2883-94. doi: 10.1021/cr5005953. Epub 2015 Mar 18. Review. No abstract available.

PMID:
25785489
12.

Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.

Liu L, Zhao S, Li F, Li E, Kang R, Luo L, Luo J, Wan S, Zhao Z.

J Sex Med. 2016 Sep;13(9):1297-310. doi: 10.1016/j.jsxm.2016.07.006. Epub 2016 Jul 27. Review.

PMID:
27475241
13.

Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?

Kosaka T, Miyajima A, Oya M.

Front Oncol. 2014 Sep 16;4:247. doi: 10.3389/fonc.2014.00247. eCollection 2014. Review.

14.

Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia.

Irwig MS.

Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):248-53. doi: 10.1097/MED.0000000000000158. Review.

PMID:
25871957
15.

Compounded Testosterone Troches TO OPTIMIZE HEALTH AND THE TESTOSTERONE CONTROVERSY.

Guth MA.

Int J Pharm Compd. 2015 May-Jun;19(3):195-203. Review.

PMID:
26714360
16.

Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.

Neto WK, Gama EF, Rocha LY, Ramos CC, Taets W, Scapini KB, Ferreira JB, Rodrigues B, Caperuto É.

Age (Dordr). 2015 Feb;37(1):9742. doi: 10.1007/s11357-014-9742-0. Epub 2015 Feb 1. Review.

17.

Sex steroids and cardiovascular disease.

Yeap BB.

Asian J Androl. 2014 Mar-Apr;16(2):239-47. doi: 10.4103/1008-682X.122357. Review.

18.

5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis.

Traish AM, Guay AT, Zitzmann M.

Horm Mol Biol Clin Investig. 2014 Dec;20(3):73-80. doi: 10.1515/hmbci-2014-0025. Review.

PMID:
25460297
Items per page

Supplemental Content

Write to the Help Desk